The effect of tissue type-plasminogen activator deletion and associated fibrin(ogen) deposition on macrophage localization in peritoneal inflammation

Thrombosis and Haemostasis

Volumn 95, Issue 4, 2006, Pages 659-667

  Cook, Andrew D ^a   Vlahos, Ross ^a   Massa, Christine M ^a   Braine, Emma L ^a   Lenzo, Jason C ^a   Turner, Amanda L ^a   Way, Kerrie J ^a   Hamilton, John A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Fibrin(olysis); Macrophages; Peritonitis; Tissue type plasminogen activator; Urokinase type plasminogen activator

Indexed keywords

ANTIGEN; CD11B ANTIGEN; FIBRINOGEN; PLASMIN; THIOGLYCOLIC ACID; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL COUNT; CELL INFILTRATION; CELL POPULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE COURSE; FIBRINOLYSIS; GENE DELETION; INFLAMMATION; MACROPHAGE MIGRATION; MONITORING; MOUSE; MOUSE MUTANT; NONHUMAN; PERITONEAL CAVITY; PERITONEUM EXUDATE; PERITONITIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; REGULATORY MECHANISM; RODENT; STAINING; SURGICAL TECHNIQUE; WILD TYPE;

ANIMALS; FIBRINOGEN; GENE DELETION; INFLAMMATION; MACROPHAGES; METHYLATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PERITONEUM; PERITONITIS; TISSUE PLASMINOGEN ACTIVATOR; URINARY PLASMINOGEN ACTIVATOR;

EID: 33645752101     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH05-06-0405     Document Type: Article

References (47)

1. Dano K, Andreasen PA, Grondahl-Hansen J, et al. Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 1985; 44: 139-266.
2. Blasi F, Vassalli JD, Dano K. Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors. J Cell Biol 1987; 104: 801-4.
3. Saksela O, Rifkin DB. Cell-associated plasminogen activation: regulation and physiological functions. Annu Rev Cell Biol 1988; 4: 93-126.
4. Akassoglou K, Kombrinck KW, Degen JL, et al. Tissue plasminogen activator-mediated fibrinolysis protects against axonal degeneration and demyelination after sciatic nerve injury. J Cell Biol 2000; 149: 1157-66.
5. Carmeliet P, Bouche A, De Clereq C, et al. Biological effects of disruption of the tissue-type plasminogen activator, urokinase-type plasminogen activator, and plasminogen activator inhibitor-1 genes in mice. Ann NY Acad Sci 1995; 748: 367-81; discussion 81-2.
6. Busso N, Hamilton JA. Extravascular coagulation and the plasminogen activator/plasmin system in rheumatoid arthritis. Arthritis Rheum 2002; 46: 2268-79.
7. Cook AD, Braine EL, Campbell IK, et al. Differing roles for urokinase and tissue-type plasminogen activator in collagen-induced arthritis. Am J Pathol 2002; 160:917-26.
8. Busso N, Peclat V, Van Ness K, et al. Exacerbation of antigen-induced arthritis in urokinase-deficient mice. J Clin Invest 1998; 102: 41-50.
9. Yang YH, Carmeliet P, Hamilton JA. Tissue-type plasminogen activator deficiency exacerbates arthritis. J Immunol 2001; 167: 1047-52.
10. Nelson DS. Reaction to antigens in vivo of the peritoneal macrophages of guinea-pigs with delayed type hypersensitivity. Effects of anticoagulants and other drugs. Lancet 1963; 2: 175-6.
11. Haskill S, Becker S. Disappearance and reappearance of resident macrophages: importance in C. parvum-induced tumoricidal activity. Cell Immunol 1985; 90: 179-89.
12. Barth MW, Hendrzak JA, Melnicoff MJ, et al. Review of the macrophage disappearance reaction. J Leukoc Biol 1995; 57: 361-7.
13. Carmeliet P, Schoonjans L, Kieckens L, et al. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 1994; 368: 419-24.
14. Ploplis VA, French EL, Carmeliet P, et al. Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice. Blood 1998; 91: 2005-9.
15. Ploplis VA, Castellino FJ. Gene targeting of components of the fibrinolytic system. Thromb Haemost 2002: 87: 22-31.
16. Leenen PJ, de Bruijn MF, Voerman JS, et al. Markers of mouse macrophage development detected by monoclonal antibodies. J Immunol Methods 1994; 174: 5-19.
17. Sudo T, Nishikawa S, Ogawa M, et al. Functional hierarchy of c-kit and c-fms in intramarrow production of CFU-M. Oncogene 1995; 11: 2469-76.
18. Cook AD, Braine EL, Hamilton JA. The phenotype of inflammatory macrophages is stimulus dependent: implications for the nature of the inflammatory response. J Immunol 2003; 171: 4816-23.
19. Cook AD, Braine EL, Hamilton JA. Stimulus-dependent requirement for granulocyte-macrophage colony-stimulating factor in inflammation. J Immunol 2004; 173: 4643-51.
20. Zhang ZG, Chopp M, Goussev A, et al. Cerebral microvascular obstruction by fibrin is associated with upregulation of PAI- 1 acutely after onset of focal embolic ischemia in rats. J Neurosci 1999; 19: 10898-907.
21. Nelson DS, Boyden SV. The loss of macrophages from peritoneal exudates following the injection of antigens into guinea-pigs with delayed-type hypersensitivity. Immunology 1963; 6: 264-75.
22. Szaba FM, Smiley ST. Roles for thrombin and fibrin(ogen) in cytokine/ chemokine production and macrophage adhesion in vivo. Blood 2002; 99: 1053-9.
23. Chapman HA, Jr., Vavrin Z, Hibbs JB, Jr. Coordinate expression of macrophage procoagulant and fibrinolytic activity in vitro and in vivo. J Immunol 1983; 130:261-6.
24. Henderson RB, Hobbs JA, Mathies M, et al. Rapid recruitment of inflammatory monocytes is independent of neutrophil migration. Blood 2003; 102: 328-35.
25. Chan J, Leenen PJ, Bertoncello I, et al. Macrophage lineage cells in inflammation: characterization by colony-stimulating factor-1 (CSF-1) receptor (c-Fms), ER-MP58, and ER-MP20 (Ly-6C) expression. Blood 1998; 92: 1423-31.
26. Miller LJ, Schwarting R, Springer TA. Regulated expression of the Mac-1, LFA-1, p150, 95 glycoprotein family during leukocyte differentiation. J Immunol 1986; 137: 2891-900.
27. Flick MJ, Du X, Witte DP, et al. Leukocyte engagement of fibrin(ogen) via the integrin receptor αMβ2/Mac-1 is critical for host inflammatory response in vivo. J Clin Invest 2004; 113: 1596-606.
28. Ciano PS, Colvin RB, Dvorak AM, et al. Macrophage migration in fibrin gel matrices. Lab Invest 1986; 54: 62-70.
29. Busuttil SJ, Ploplis VA, Castellino FJ, et al. A central role for plasminogen in the inflammatory response to biomaterials. J Thromb Haemost 2004; 2: 1798-805.
30. Ploplis VA, Carmeliet P, Vazirzadeh S, et al. Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice. Circulation 1995; 92: 2585-93.
31. Romer J, Bugge TH, Pyke C, et al. Plasminogen and wound healing, Nat Med 1996; 2: 725.
32. Melnicoff MJ, Horan PK, Morahan PS. Kinetics of changes in peritoneal cell populations following acute inflammation. Cell Immunol 1989; 118: 178-91.
33. Bellingan GJ, Caldwell H, Howie SE, et al. In vivo fate of the inflammatory macrophage during the resolution of inflammation: inflammatory macrophages do not die locally, but emigrate to the draining lymph nodes. J Immunol 1996; 157: 2577-85.
34. Cao C, Lawrence DA, Strickland DK, et al. A specific role of integrin Mac- 1 in accelerated macrophage efflux to the lymphatics. Blood 2005; 106: 3234-41.
35. Leak LV. Interaction of mesothelium to intraperitoneal stimulation. I. Aggregation of peritoneal cells. Lab Invest 1983; 48: 479-91.
36. Hart PH, Vitti GF, Burgess DR, et al. Human monocytes can produce tissue-type plasminogen activator. J Exp Med 1989; 169: 1509-14.
37. Hart PH, Burgess DR, Vitti GF, et al. Interleukin-4 stimulates human monocytes to produce tissue-type plasminogen activator. Blood 1989; 74: 1222-5.
38. Soo KS, Northeast AD, Happerfield LC, et al. Tissue plasminogen activator production by monocytes in venous thrombolysis. J Pathol 1996; 178: 190-4.
39. Myrhe-Jensen O, Larsen SB, Astrup T. Fibrinolytic activity in serosal and synovial membranes. Rats, guinea pigs, and rabbits. Arch Pathol 1969; 88: 623-30.
40. Raftery AT. Regeneration of peritoneum: a fibrinolytic study. J Anat 1979; 129: 659-64.
41. Vipond MN, Whawell SA, Thompson JN, et al. Peritoneal fibrinolytic activity and intra-abdominal adhesions. Lancet 1990; 335: 1120-2.
42. Ellis H, Harrison W, Hugh TB. The healing of peritoneum under normal and pathological conditions. Br J Surg 1965; 52: 471-6.
43. Thompson JN, Paterson-Brown S, Harbourne T, et al. Reduced human peritoneal plasminogen activating activity: possible mechanism of adhesion formation. Br J Surg 1999; 76: 382-4.
44. Gervin AS, Puckett CL, Silver D. Serosal hypofibrinolysis. A cause of postoperative adhesions. Am J Surg 1973; 125: 80-8.
45. Buckman RF, Woods M, Sargent L, et al. A unifying pathogenetic mechanism in the etiology of intraperitoneal adhesions. J Surg Res 1976; 20: 1-5.
46. Hau T, Payne WD, Simmons RL. Fibrinolytic activity of the peritoneum during experimental peritonitis. Surg Gynecol Obstet 1979; 148: 415-8.
47. Thompson JN. Preventing adhesions. Lancet 1995; 346: 1382.